| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |